The CRISPR-Cas9 “drag-and-drop” gene editing technique has been used in its first human trial, reports Nature. Scientists at Sichuan University in Chengdu, China began a trial last month to treat a lung cancer patient. "Earlier clinical trials using cells edited with a different technique have excited clinicians.
The introduction of CRISPR, which is simpler and more efficient than other techniques, will probably accelerate the race to get gene-edited cells into the clinic across the world,... read more